培米替尼购买途径

Pemetinib is a kinase inhibitor indicated for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with fibroblast growth factor receptor 2 (FGFR2) fusions or other rearrangements as detected by an FDA-approved test; it blocks the growth and spread of tumors by inhibiting FGFR2 in tumor cells.

This indication is approved under expedited approval based on overall response rate and response time. Continued approval for this indication may be contingent on verification and description of clinical benefit in confirmatory trials.

Pemetinib usage and dosage:

Before initiating treatment with pemetinib, confirm the presence of FGFR2 fusions or rearrangements.

The recommended dose is 13.5 mg orally daily for 14 days, followed by 7 days off in a 21-day cycle. Continue treatment until disease progression or unacceptable toxicity.

Swallow the tablets whole, with or without food.

Where to buy pemetinib:

Pemetinib has not yet been officially launched in China. Therefore, it is not on display and sold in China. Patients in need can purchase the version listed abroad. The price of pemetinib varies due to exchange rate fluctuations. Please consult the medical companion for specific prices!

If you want to buy medicines listed abroad, but it is inconvenient to go abroad, the most reliable way is to buy them through regular domestic overseas medical service institutions, which will sign a guarantee contract for you. The medicines and money will not be handled by them, and will be mailed to the patient by direct mail, guaranteeing 100% authenticity!

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: